Mumbai-based company Supriya Lifescience Ltd, specializing in active pharmaceutical ingredients (API), has announced a groundbreaking collaboration with United States-based Plasma Nutrition, Inc. This exclusive technology licensing agreement grants Supriya Lifescience the sole rights for manufacturing and marketing Ingredient Optimized Protein (ioProtein) in India. The partnership is aimed at introducing this optimized protein into the Indian […]
Ami Organics has signed a multi-year, multi-tonne agreement with Fermion, a wholly-owned subsidiary of Finland-based Orion Corporation for the supply of an intermediate for its patented product. Based in India, Ami Organics is involved in manufacturing advance pharmaceutical intermediates and speciality chemicals. The company is claimed to have developed and commercialized more than 450 pharma […]
PI Industries Ltd (PIIND), an Indian agri-sciences company, said that its previously announced INR 1,530 crores acquisition of the active pharmaceutical ingredient (API) business division of lnd Swift Laboratories Limited (ISLL) has been terminated. The closing of the deal was subject to the meeting of pre-defined preceding conditions by 31 October 2021. According to PI […]
PI Industries Ltd, an Indian agri-sciences company, has agreed to acquire the API business division of lnd Swift Laboratories Limited (ISLL) for INR 1,530 crores ($210 million). Based in Chandigarh, lnd Swift Laboratories manufactures and exports active pharmaceutical ingredients (API) and advanced intermediates. The Indian pharma company serves the API requirements of regulated and soft […]
Mangalam Drugs and Organics Limited, an Indian manufacturer of active pharmaceutical ingredients (APIs), has commissioned a new intermediate manufacturing facility in Vapi, Gujarat. The API manufacturer said that the intermediate is an import substitute and a key raw material which it was importing from China. Mangalam Drugs and Organics claimed that it is the first […]
Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen Pharmacare in a deal valued up to €400 million, as per the latest pharma acquisition news. The acquisition includes shares in Aspen Japan and associated assets held by the South […]
Olon, a prominent developer and manufacturer of active pharmaceutical ingredients (API) based in Italy, has strategically expanded its global operations with the acquisition of a generics chemical operations API manufacturing plant located in Mahad, Maharashtra, India. This move is part of Olon’s ambitious strategy to accelerate growth by incorporating new Contract Development and Manufacturing Organization […]
